Posts

Showing posts from 2025

MASH in 2025: New Therapies, New Challenges

China’s NRDL: The World’s Largest Market Access Event Is Underway

GLP-1s and the Rise of Consumer-Led Pharma: What the Obesity Market Signals for the Future of Access

Most-Favored-Nation Drug Pricing: Policy Shift or Pressure Tactic?

Trump’s Drug Pricing Executive Order: Uncertainty for Pharma Leaders

Tariffs on Pharmaceuticals: Are Drug Prices Set to Rise?

Access To The New Alzheimer's Drugs: Why HTA Bodies Are Saying No